UPRES EA4530, Université Paris-Sud, Faculté de Pharmacie, 5 rue Jean-Baptiste Clément, 92296 Châtenay-Malabry cedex, France.
Semin Cancer Biol. 2013 Oct;23(5):361-79. doi: 10.1016/j.semcancer.2013.06.007. Epub 2013 Jun 27.
The modulation of macroautophagy is now recognized as one of the hallmarks of cancer cells. There is accumulating evidence that autophagy plays a role in the various stages of tumorigenesis. Depending on the type of cancer and the context, macroautophagy can be tumor suppressor or it can help cancer cells to overcome metabolic stress and the cytotoxicity of chemotherapy. Recent studies have shed light on the role of macroautophagy in tumor-initiating cells, in tumor immune response cross-talk with the microenvironment. This review is intended to provide an up-date on these aspects, and to discuss them with regard to the role of the major signaling sub-networks involved in tumor progression (Beclin 1, MTOR, p53 and RAS) and in regulating autophagy.
自噬的调控被认为是癌细胞的特征之一。越来越多的证据表明,自噬在肿瘤发生的各个阶段都发挥作用。根据癌症的类型和具体情况,巨自噬可以作为肿瘤抑制因子,也可以帮助癌细胞克服代谢应激和化疗的细胞毒性。最近的研究揭示了巨自噬在肿瘤起始细胞中的作用,以及与微环境的肿瘤免疫反应相互作用。本文旨在对这些方面进行综述,并结合涉及肿瘤进展的主要信号转导子网络(Beclin 1、MTOR、p53 和 RAS)和调节自噬的作用来讨论这些方面。